Atlas Trials

Evaluation of the Signaling Path of Emiline1-TGFβ in the Myogenic Tone of Resistance Arteries in a Population of Normotensive and Hypertensive Subjects

Clinical trial NCT02312193 · COMPLETED

Trial details

NCT number
NCT02312193
Sponsor
Neuromed IRCCS
Status
COMPLETED
Study type
OBSERVATIONAL
Hypertension
Start date
2015-01-01
Primary completion
2020-12-01
Enrollment
95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.